AB2 Bio ^Company

AB2 Bio Ltd is a drug discovery and development company located at the innovation park of the \xc9cole Polytechnique F\xe9d\xe9rale de Lausanne (EPFL). They are focused on developing innovative therapies for the treatment of inflammatory diseases with large unmet medical needs. Their drugs aim to target the underlying causes of inflammation-based diseases, rather than just treating the symptoms. AB2 Bio has advanced clinical programs in NLRC4 MAS and in adult onset still's disease, and their drugs have demonstrated a high tolerance and excellent safety profile in extensive phase I and IB clinical trials.